DAB2IP and urinary bladder carcinoma: Regarding radiotherapy, DAB2IP loss promotes bladder cancer cells resistance to ionizing radiation (IR) by increasing the expression of ataxia‐telangiectasia mutated (ATM) and the activation of NF-κB pathway and p38MAPK.